0.18
-9.40%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Accendra Health
From its filings with the US Securities and Exchange Commission
Accendra Health is based in Glen Allen, Virginia and is incorporated in Virginia. Its shares trade on NYSE under the ticker ACH. The SEC classifies its business as wholesale-medical, dental & hospital equipment & supplies. In the fiscal year to 31 December 2025, it reported revenue of $2.76bn and a net loss of $1.10bn. At that date it held total assets of $2.45bn and shareholders' equity of −$461.0m.
Accendra Health, Inc. (f/k/a Owens & Minor, Inc.) and subsidiaries (Accendra Health, we, us, our or the Company) is a leading nationwide provider of products, technology, and services that supports health beyond the hospital for millions of people each year. We connect patients, providers, and insurers, delivering innovative solutions that help promote better health outcomes and improve quality of life for people living with chronic, complex, and acute health conditions. Together, our trusted brands, Apria and Byram Healthcare, bring nearly 90 years of combined experience in promoting health beyond the hospital in communities across the country. We are headquartered in Richmond, Virginia. The description of our business should be read in conjunction with the consolidated financial statements and supplementary data included in this Form 10-K.
On October 7, 2025, we entered into an Equity Purchase Agreement, (the Purchase Agreement) by and among the Company, Dominion Healthcare Acquisition Corporation, a Delaware corporation (the Purchaser), and Dominion Healthcare Holdings, L.P., a Delaware limited partnership (Purchaser Parent) to sell the Products & Healthcare Services (P&HS) business, for an aggregate of $375 million in cash, subject to certain adjustments for cash, indebtedness, net working capital and transaction expenses. On December 31, 2025, we completed the sale of the P&HS business pursuant to the Purchase Agreement. We have retained a 5% equity interest in the P&HS business.
Quoted from its 10-K, filed 20 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 17 Mar 1980
- Employees
- 6,500
- Website
- owens-minor.com ↗
- Head office
- 4435 WATERFRONT DRIVE, GLEN ALLEN, VA
- Incorporated in
- VA
- Classification
- Wholesale-Medical, Dental & Hospital Equipment & Supplies
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Mark BeckIndependent Chairman of the Board$455,000
- Mr. Edward PesickaPresident, Chief Executive Officer, Director, since 2019$10.7m
- Mr. Jonathan LeonChief Financial Officer, Executive Vice President$2.3m
- Ms. Jennifer StoneChief Human Resources Officer, Executive Vice President
- Mr. Snehashish SarkarExecutive Vice President, Chief Information Officer
- Mr. Heath GallowayExecutive Vice President, General Counsel, Corporate Secretary$2.2m
- Mr. Perry BernocchiExecutive Vice President, Chief Executive Officer of Patient Direct Segment$3.7m
- Mr. Andrew LongExecutive Vice President, Chief Executive Officer of Products and Healthcare Services$4.0m
- Mr. Michael LowrySenior Vice President, Corporate Controller, Chief Accounting Officer$310,836
- Lt. Gen. Gwendolyn BinghamIndependent Director$355,000
- Mr. Kenneth Gardner-SmithIndependent Director$330,000
- Mr. Robert HenkelIndependent Director$355,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 95
- Environment
- 99
- Social
- 99
- Governance
- 88
- Direct emissions (scope 1)
- 155,255 t
- Energy emissions (scope 2)
- 169,203 t
- Value chain emissions (scope 3)
- 2,043,747 t
- Women in the workforce
- 50%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Owens & Minor Inc has a strong market presence as a leading distributor of medical and surgical supplies, which provides a competitive advantage in the industry.
- The company has a diverse customer base, including hospitals, healthcare systems, and healthcare providers, ensuring a steady stream of revenue.
- Owens & Minor Inc has established long-standing relationships with suppliers, enabling favorable terms and access to a wide range of products.
Weaknesses
- The company heavily relies on a few key suppliers, which poses a risk to the supply chain and exposes Owens & Minor Inc to potential disruptions in the event of supplier-related issues.
- Owens & Minor Inc has significant debt, which can limit financial flexibility and increase interest expense.
- The company faces intense competition in the healthcare distribution industry, putting pressure on profit margins.
Opportunities
- The COVID-19 pandemic has increased demand for medical supplies, presenting an opportunity for Owens & Minor Inc to capture additional market share and expand revenue.
- Growing healthcare expenditure worldwide creates potential for the company to expand its sales globally and diversify its customer base.
- The trend towards e-commerce in the healthcare industry opens opportunities for Owens & Minor Inc to enhance its online distribution channels and reach a broader customer segment.
Threats
- Possible healthcare reforms and changes in regulations can impact the company's operations and profitability.
- Increased pricing pressure from healthcare providers and government agencies could adversely affect Owens & Minor Inc's profit margins.
- The emergence of new competitors and consolidation within the industry may intensify competition and potentially decrease market share.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.